The authors present current data on the etiology, pathogenesis, clinical manifestations of celiac disease in children of different ages, associated diseases, laboratory and instrumental diagnostics, diet therapy, additional treatment methods, vaccination, and follow-up of children with celiac disease based on the developed clinical guidelines “Celiac Disease. Children”.
25 May 2023 in Experimental and Clinical Gastroenterology
Inflammatory bowel disease (IBD) is a group of severe systemic diseases with a multiple intestinal and extraintestinal manifestations (EIM). EIM can affect any organ systems, determine the course, therapy and prognosis of the underlying disease. The frequency of EIM (6–80%) differs significantly in studies depending on the cohort of patients (number, age of patients, IBD phenotype). In 6–10% of children EIM are the first symptoms of the disease. The classification of EIM most often depends on the activity of the disease in the intestine. The most commonly affected «target organs» in children and adults are joints, skin and mucous membranes, eyes, and the hepatobiliary system. Physical development delay is specific for children IBD, not always reversible. The article highlights the incidence of ulcerative colitis and Crohn’s disease EIM in children and adults, analyzes the basics of epidemiology, pathogenesis, clinical manifestations, approaches to the diagnosis and treatment of arthritis, growth disorders, mucocutaneous, ocular and hepatobiliary EIM of IBD in children. Therapy of EIM associated with IBD activity is aimed at controlling the underlying disease and includes a wide range of drugs, ФНОα antagonists are the most effective. The treatment protocols for other EIM are not standardized in either adult or pediatric practice and are significantly less successful.
Nowadays the only effective method of celiac disease management and preventing its complications is strict lifelong gluten-free diet. Compliance to it can be considerably difficult. This review provides the analysis of updated data on the quality of life (QoL) of patients with celiac disease on gluten-free diet. Significant impact of extraintestinal symptoms on QoL occurring during nutritional treatment was noted. However, the use of QoL assessment to determine the nutritional treatment efficacy in children with celiac disease has not been sufficiently studied. The need for psychological correction and social adaptation of patients with celiac disease is discussed.
Celiac disease and eating disorders are complex chronic diseases characterized by weight changes, malnutrition, and gastrointestinal symptoms. Celiac disease patients are treated by following a strict gluten-free diet, which may inadvertently contribute to eating disorders. Conversely, eating disorders can mask and aggravate the clinical manifestations of celiac disease, which leads to a prolongation of the diagnosis of the disease and problems with the treatment of such patients. The available data indicate an increased risk of developing eating disorders in patients with celiac disease and vice versa, suggesting a potential bidirectional relationship between these diseases. This review examines the mechanisms and clinical consequences of the interaction between celiac disease and eating disorders, and suggests strategies for comprehensive screening and treatment to improve the quality of life of patients with both conditions.